Sort
51,570 grants matching “autoimmune disease”
Novel Strategies for Precision T-cell Therapies
$520,564Steven C. Almo · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA
Novel Strategies for Precision T-cell Therapies
$520,564Steven C. Almo · Albert Einstein College Of Medicine · R01 · FY2020 · CA
Novel Strategies for Precision T-cell Therapies
$520,564Steven C. Almo · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA
Specificity and Molecular Definition of Pathogenic Lymphocytes in Sjogren's Syndrome
$520,558A. Darise Farris · Oklahoma Medical Research Foundation · R01 · FY2022 · AR
Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE
$520,458Shaun William Jackson · Seattle Children'S Hospital · R01 · FY2025 · AR
Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE
$520,458Shaun William Jackson · Seattle Children'S Hospital · R01 · FY2024 · AR
Peer Approaches to Lupus Self-Management (PALS)
$520,450Edith Marie Williams · Medical University Of South Carolina · R01 · FY2018 · NR
Career Development and Outreach in Musculoskeletal, Autoimmune and Skin Disease
$520,430Mario Cerritelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIJ · FY2011 · AR
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICS
$520,396Paul M Allen · Washington University · T32 · FY2015 · AI
Small Molecules and Antibodies Interacting at the TSH Receptor
$520,334Terry Francis Davies · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · DK
Prediction and Prevention of Type 1 Diabetes - TrialNet
$520,280Dorothy J Becker · University Of Pittsburgh At Pittsburgh · U01 · FY2013 · DK
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
$520,230Raymond J Dingledine · Emory University · R01 · FY2023 · NS
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
$520,230Raymond J Dingledine · Emory University · R01 · FY2020 · NS
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
$520,230Raymond J Dingledine · Emory University · R01 · FY2021 · NS
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
$520,230Raymond J Dingledine · Emory University · R01 · FY2022 · NS
Newborn Screening for T-Cell Disorders: Spectrum and Outcomes
$520,208Jennifer Maxwell Puck · University Of California, San Francisco · R01 · FY2015 · AI
Defining WASp-dependent pathways in replication stress
$520,207Yatin M Vyas · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · AI
Transcriptional Regulation of the Immune Response
$520,195Laurie H Glimcher · Harvard School Of Public Health · R01 · FY2009 · AI
Alcohol and intestinal microvascular endothelium-immune axis and the role of gut derived immune nutrients
$520,191Gail Ann Cresci · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AA
Regulatory T cells in allogeneic transplantation
$520,186Robert S Negrin · Stanford University · R01 · FY2012 · HL
HT screens for the disruption of the T cell receptor CD3 interface
$520,179Luc Teyton · Scripps Research Institute, The · R01 · FY2013 · AI
Role of Telomere and telomerase In Human Lymphocyte Function and Aging
$520,160Nan-Ping Weng · National Institute On Aging · ZIA · FY2021 · AG
Human Antibody Tolerance in Normal and SLE
$520,147Michel C Nussenzweig · Baylor Research Institute · P50 · FY2009 · AR
Environmental Oxygen Transitions and Aspergillosis Disease Progression
$520,089Robert Andrew Cramer · Dartmouth College · R01 · FY2019 · AI
WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunity
$520,046Brian M Iritani · University Of Washington · R01 · FY2023 · AI